Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Consensus Recommendation of "Hold" by Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) have been given a consensus recommendation of "Hold" by the thirteen research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $75.27.

A number of research analysts have weighed in on the company. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. UBS Group boosted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada lowered their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. Finally, Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research report on Friday, February 21st.

Ryan Specialty Stock Performance

Shares of RYAN stock traded down $2.04 during trading on Thursday, reaching $68.47. 1,917,025 shares of the company's stock traded hands, compared to its average volume of 936,052. The firm's 50-day moving average is $69.67 and its 200 day moving average is $68.72. The company has a market capitalization of $17.93 billion, a P/E ratio of 99.23, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty has a 1 year low of $48.48 and a 1 year high of $77.16. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Remove Ads

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Equities research analysts expect that Ryan Specialty will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. Ryan Specialty's dividend payout ratio is 69.57%.

Insider Buying and Selling

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the transaction, the director now directly owns 35,609 shares of the company's stock, valued at approximately $2,349,837.91. This trade represents a 49.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,360 shares of company stock worth $16,006,428 in the last quarter. 11.10% of the stock is owned by insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of large investors have recently bought and sold shares of RYAN. Raymond James Financial Inc. bought a new position in shares of Ryan Specialty in the fourth quarter worth approximately $94,484,000. Norges Bank purchased a new stake in Ryan Specialty during the 4th quarter valued at $78,358,000. Millennium Management LLC grew its holdings in Ryan Specialty by 1,111.4% in the 4th quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock worth $75,329,000 after acquiring an additional 1,077,169 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the period. Finally, CIBC Private Wealth Group LLC increased its position in shares of Ryan Specialty by 6,911.0% in the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock valued at $48,036,000 after acquiring an additional 774,718 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.